Intra-Cellular Therapies, Inc. Share | Buy US Stock from India on Kuvera

Q: Can I buy Intra-Cellular Therapies, Inc. shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Intra-Cellular Therapies, Inc. stocks after a simple registration process. </div>

Q: How to buy Intra-Cellular Therapies, Inc. shares in India?

<div> To buy Intra-Cellular Therapies, Inc. shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Intra-Cellular Therapies, Inc. and you are done!</div> </div>

Q: What is the share price of Intra-Cellular Therapies, Inc.?

<div>The share price of Intra-Cellular Therapies, Inc. is USD 70.34 as on 2 May.</div>

Q: What is the Market Capitalization of Intra-Cellular Therapies, Inc.?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Intra-Cellular Therapies, Inc. is USD 6.81B as on 2 May.</div>

Q: What is the PE ratio of Intra-Cellular Therapies, Inc.?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Intra-Cellular Therapies, Inc. is N/A as on 2 May. </div>

Q: Is Intra-Cellular Therapies, Inc. a good stock to buy?

<div>Kuvera provides relevant fundamental details of Intra-Cellular Therapies, Inc. to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Intra-Cellular Therapies, Inc. operate?

<div> Intra-Cellular Therapies, Inc. operates in Healthcare / Drug manufacturers - specialty & generic

Healthcare Drug manufacturers - specialty & generic

$70.34

-2.39

(2 May)

Loading Chart

Previous close

$70.34

Open

$70.34

Today’s high

$73.77

Today’s low

$69.98

52W low

$45.50

52W high

$84.89

11.16%

39.04%

Shares O/S

96.81M

Market cap

6.81B

Insights

No insights found for this stock

Compare with other stock

About Intra-Cellular Therapies, Inc.

Intra-Cellular Therapies, Inc. is a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders. The Company leverages intracellular approach to develop treatments for people living with complex psychiatric and neurologic diseases. The Company’s product, CAPLYTA (lumateperone), is an oral, once daily atypical antipsychotic approved in adults for the treatment of schizophrenia and the treatment of depressive episodes associated with bipolar I or II disorder (bipolar depression) as monotherapy and as adjunctive therapy with lithium or valproate.

Its pipeline includes several product candidates in clinical development and additional product candidates in non-clinical testing, such as ITI-1284-ODT-SL program, Phosphodiesterase type I inhibitor (PDE1) program, ITI-333 program, and ITI-1500 Non-Hallucinogenic Psychedelic program. ITI-1284 is a deuterated form of lumateperone, a new chemical entity. .

FAQs

Can I buy Intra-Cellular Therapies, Inc. shares in India?

How to buy Intra-Cellular Therapies, Inc. shares in India?

What is the share price of Intra-Cellular Therapies, Inc.?

What is the Market Capitalization of Intra-Cellular Therapies, Inc.?

What is the PE ratio of Intra-Cellular Therapies, Inc.?

Is Intra-Cellular Therapies, Inc. a good stock to buy?

In which sector / industry does Intra-Cellular Therapies, Inc. operate?